Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
C. Magin (Aurora, United States of America). Bioengineered models of human lung disease. International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung

Member's Comments

No comment yet.

Related content which might interest you: Human lung scaffolds to model lung disease and tissue regeneration Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration Year: 2018 Acellular human lung scaffolds to model lung disease and tissue regeneration Source: Eur Respir Rev, 27 (148) 180021; 10.1183/16000617.0021-2018 Year: 2018 Murine models of cardiovascular damage in lung diseases Source: Eur Respir Monogr 2020; 88: 31-46 Year: 2020 Progress and applications of mouse models for human lung cancer Source: Eur Respir J 2010; 35: 426-443 Year: 2010 Ferret respiratory disease models for the study of lung stem cells Source: Eur Respir Monogr 2021; 91: 273-289 Year: 2021 Progress towards human lung regeneration in end-stage respiratory failure: studying human lung development in vitro using organoid cultures of human embryonic lung stem cells Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration Year: 2018 Microengineered systems to mimic human lung pathophysiology Source: International Congress 2017 – Innovative approaches to model human lung diseases Year: 2017 Towards human lung regeneration in end-stage respiratory failure: genetically-modifiable 3D organoid culture of human embryonic lung stem cells enables for the first time the study of human lung development in vitro Source: ERS Lung Science Conference 2018 Year: 2018 Optimising disease models for lung diseases and drug development Source: International Congress 2015 – Development and application of new approaches for respiratory disease research Year: 2015 The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 Siphonage lung disease Source: Virtual Congress 2020 – Respiratory critical care Year: 2020 3D models of human lung development and disease using pluripotent stem cells Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung Year: 2019 Characterization of human airway epithelial cell lines as in vitro models of chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 Are risk predicting models useful for estimating survival in rheumatoid arthritis-associated interstitial lung disease? Source: International Congress 2016 – Connective tissue disorders Year: 2016 Use of biomaterials to tissue engineer 3D models with lung organoids for in-vitro disease modelling Source: Virtual Congress 2020 – Lung epithelial development and repair in three-dimensions Year: 2020 Connective tissue disease-related interstitial lung disease and lung cancer Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018 Interferon-γ pretreated human MSC show improved efficiency in humanized mice model of pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Suppression of epithelial abnormalities by nintedanib in induced-rheumatoid arthritis-associated interstitial lung disease mouse model Source: ERJ Open Res, 7 (4) 00345-2021; 10.1183/23120541.00345-2021 Year: 2021